Closing the Evidence Gap of Cash Transfer for Tuberculosis-Affected Households; Comment on “Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? – A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India”

Document Type : Commentary

Author

1 Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia

2 Primary Health Care Research and Innovation Center, Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia

Abstract

Achieving the targets of eliminating tuberculosis (TB) requires a combination of biomedical, epidemiological, and social approaches. Having hitted by the coronavirus disease 2019 (COVID-19) pandemic which diminishes the financial capacity of TB-affected households, the importance of delivering socioeconomic support to TB-affected household emerges. However, the evidence of TB-related socioeconomic support is still scarce, and some questions are left unanswered. A sequential explanatory mixed-methods study by Dave and Rupani shows that the direct benefit transfer (DBT), a form of cash transfer, to TB-affected households improves TB treatment outcomes in India despite the challenges. Some critical issues remain to be discussed: trading-off between the amount of cash and its sustainability, choosing the most appropriate support packages, detecting, and reaching the target population, and arranging the most effective delivery strategy. Knowledge gap remains to be answered, and a global research agenda and political commitment are critical to encourage more evidence in delivering socioeconomic support for TB control.

Keywords


  1. World Health Organization (WHO). Global Tuberculosis Report 2021. WHO; 2021.
  2. Arentz M, Ma J, Zheng P, Vos T, Murray CJL, Kyu HH. The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India. BMC Infect Dis. 2022;22(1):92. doi:1186/s12879-022-07078-y
  3. Fuady A, Houweling TAJ, Mansyur M, Richardus JH. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage. Infect Dis Poverty. 2018;7(1):3. doi:1186/s40249-017-0382-3
  4. Muniyandi M, Thomas BE, Karikalan N, et al. Association of tuberculosis with household catastrophic expenditure in South India. JAMA Netw Open. 2020;3(2):e1920973. doi:1001/jamanetworkopen.2019.20973
  5. Chandra A, Kumar R, Kant S, Krishnan A. Costs of TB care incurred by adult patients with newly diagnosed drug-sensitive TB in Ballabgarh block in northern India. Trans R Soc Trop Med Hyg. 2022;116(1):63-69. doi:1093/trstmh/trab060
  6. Fuady A, Houweling TAJ, Richardus JH. COVID-19 and tuberculosis-related catastrophic costs. Am J Trop Med Hyg. 2020;104(2):436-440. doi:4269/ajtmh.20-1125
  7. Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375(9728):1814-1829. doi:1016/s0140-6736(10)60483-7
  8. Wingfield T, Boccia D, Tovar M, et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med. 2014;11(7):e1001675. doi:1371/journal.pmed.1001675
  9. Fuady A, Houweling TAJ, Mansyur M, Burhan E, Richardus JH. Catastrophic costs due to tuberculosis worsen treatment outcomes: a prospective cohort study in Indonesia. Trans R Soc Trop Med Hyg. 2020;114(9):666-673. doi:1093/trstmh/traa038
  10. Wingfield T, Tovar MA, Huff D, et al. A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Health Organ. 2017;95(4):270-280. doi:2471/blt.16.170167
  11. Ciobanu A, Domente L, Soltan V, et al. Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Public Health Action. 2014;4(Suppl 2):S59-63. doi:5588/pha.14.0047
  12. Lutge E, Lewin S, Volmink J, Friedman I, Lombard C. Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial. Trials. 2013;14:154. doi:1186/1745-6215-14-154
  13. Carter DJ, Daniel R, Torrens AW, et al. The impact of a cash transfer programme on tuberculosis treatment success rate: a quasi-experimental study in Brazil. BMJ Glob Health. 2019;4(1):e001029. doi:1136/bmjgh-2018-001029
  14. Dave JD, Rupani MP. Does direct benefit transfer improve outcomes among people with tuberculosis? - A mixed-methods study on the need for a review of the cash transfer policy in India. Int J Health Policy Manag. 2022. doi:34172/ijhpm.2022.5784
  15. Boccia D, Pedrazzoli D, Wingfield T, et al. Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities. BMC Infect Dis. 2016;16:307. doi:1186/s12879-016-1529-8
  16. Timire C, Ngwenya M, Chirenda J, et al. Catastrophic costs among tuberculosis-affected households in Zimbabwe: a national health facility-based survey. Trop Med Int Health. 2021;26(10):1248-1255. doi:1111/tmi.13647
  17. Ministry of Rural Development. National Social Assistance Program. https://nsap.nic.in/circular.do?method=aboutus.
  18. Kaushal N. How public pension affects elderly labor supply and well-being: evidence from India. World Dev. 2014;56:214-225. doi:1016/j.worlddev.2013.10.029
  19. Asri V. Targeting of social transfers: are India’s poor older people left behind? World Dev. 2019;115:46-63. doi:1016/j.worlddev.2018.11.001
  20. Goswami AK, Ramadass S, Kalaivani M, Nongkynrih B, Kant S, Gupta SK. Awareness and utilization of social welfare schemes by elderly persons residing in an urban resettlement colony of Delhi. J Family Med Prim Care. 2019;8(3):960-965. doi:4103/jfmpc.jfmpc_28_19
  21. Fuady A, Houweling TAJ, Mansyur M, Burhan E, Richardus JH. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios. Infect Dis Poverty. 2019;8(1):10. doi:1186/s40249-019-0519-7
  22. Mobarak AM. Assessing social aid: the scale-up process needs evidence, too. Nature. 2022;609(7929):892-894. doi:1038/d41586-022-03039-2
  23. Rudgard WE, Evans CA, Sweeney S, et al. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: an economic modelling study. PLoS Med. 2017;14(11):e1002418. doi:1371/journal.pmed.1002418

Articles in Press, Corrected Proof
Available Online from 30 October 2022
  • Receive Date: 31 August 2022
  • Revise Date: 21 October 2022
  • Accept Date: 26 October 2022
  • First Publish Date: 30 October 2022